- Home
- INUV vs VTGN Comparison
INUV vs VTGN Comparison
Compare INUV & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INUV
- VTGN
- Stock Information
- Founded
- INUV N/A
- VTGN 1998
- Country
- INUV United States
- VTGN United States
- Employees
- INUV N/A
- VTGN N/A
- Industry
- INUV Advertising
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- INUV Consumer Discretionary
- VTGN Health Care
- Exchange
- INUV Nasdaq
- VTGN Nasdaq
- Market Cap
- INUV 62.8M
- VTGN 70.0M
- IPO Year
- INUV N/A
- VTGN N/A
- Fundamental
- Price
- INUV $3.48
- VTGN $2.13
- Analyst Decision
- INUV Strong Buy
- VTGN
- Analyst Count
- INUV 2
- VTGN 0
- Target Price
- INUV $2.00
- VTGN N/A
- AVG Volume (30 Days)
- INUV 148.4K
- VTGN 163.8K
- Earning Date
- INUV 08-07-2025
- VTGN 06-17-2025
- Dividend Yield
- INUV N/A
- VTGN N/A
- EPS Growth
- INUV N/A
- VTGN N/A
- EPS
- INUV N/A
- VTGN N/A
- Revenue
- INUV $93,478,114.00
- VTGN $486,000.00
- Revenue This Year
- INUV $28.36
- VTGN N/A
- Revenue Next Year
- INUV $12.18
- VTGN N/A
- P/E Ratio
- INUV N/A
- VTGN N/A
- Revenue Growth
- INUV 18.20
- VTGN N/A
- 52 Week Low
- INUV $1.90
- VTGN $1.90
- 52 Week High
- INUV $7.90
- VTGN $4.21
- Technical
- Relative Strength Index (RSI)
- INUV 42.03
- VTGN 35.75
- Support Level
- INUV $3.00
- VTGN $2.18
- Resistance Level
- INUV $3.80
- VTGN $2.44
- Average True Range (ATR)
- INUV 0.34
- VTGN 0.15
- MACD
- INUV -0.05
- VTGN -0.03
- Stochastic Oscillator
- INUV 43.64
- VTGN 1.89
About INUV Inuvo Inc.
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.